What you need to know about IRT software systems for clinical trial Randomization and Trial Supply Management.
What is IRT in clinical trials?
Interactive Response Technology (IRT) is a term for clinical trial management software that handles patient randomization, drug assignment, and supply chain logistics.
IRT automates critical processes like patient enrollment, randomization, treatment allocation, inventory tracking, and compliance monitoring that were traditionally handled manually or through phone systems.
Core IRT functions:
- Patient management: Screening, enrollment, randomization, and visit schedules
- Drug supply management: Inventory tracking, automated resupply, and distribution optimization
- Data integration: Real-time reporting and seamless integration with other clinical systems
IRT systems from vendors like Suvoda provide web-based interfaces with advanced configurability to handle complex protocol requirements across all trial phases.
IRT vs. RTSM: What’s the difference?
In today’s trials, the two terms are often used interchangeably. Most modern IRT systems, including Suvoda IRT, deliver full RTSM functionality.
Interactive Response Technology (IRT) refers to the technology system clinical trials use to manage key trial activities such as randomizing patients, managing drug supply and patient visits. "Interactive response" refers to how the software allows users (like site staff) to interact with the system in real time. This is the broader term.
Randomization and Trial Supply Management (RTSM) describes the specific functions the IRT system performs, like assigning participants to treatment arms and managing the flow of investigational product.
So, RTSM is what the system does, while IRT is the technology that makes it possible.
Historically, IRT described systems that allowed users like site staff, monitors, study teams to interact with trial workflows through IVRS (phone), IWRS (web), or later integrated digital interfaces. The emphasis was on the mode of interaction, not the function.
When do you need IRT for clinical trials?
IRT is important for randomized clinical trials requiring blinding or drug supply management from Phase I through Phase IV studies.
Suvoda IRT system is particularly valuable when trials involve complex protocol requirements, drug supply management and logistics, and global coordination. Even simple studies benefit from IRT's automated processes, audit trails, and regulatory compliance features that eliminate manual errors and adhere to 21 CFR Part 11 compliance.
What are the main benefits of using IRT in clinical trials?
IRT helps drive operational efficiency, cost reduction, and enhanced compliance through automated processes and real-time data access. A McKinsey study revealed significant supply chain optimization benefits, including 15-20% reduction in drug waste and costs.
Key benefits of using IRT in clinical trials:
- Cost optimization: 15-20% reduction in drug waste through intelligent forecasting
- Operational efficiency: Automated processes eliminate manual errors and speed up timelines
- Patient impact: Supports correct medication delivery and reduces missed visits
- Compliance assurance: Built-in audit trails and regulatory reporting
- Real-time visibility: Instant access to trial status and supply levels across all sites
These improvements directly impact trial success by reducing delays, minimizing costs, and helping patients receive the right treatment at the right time.
How much does IRT cost for clinical trials?
IRT typically represents 2-3% of the total study budget for Phase II and III trials. Costs vary based on trial complexity, number of sites, and customization requirements, but the return on investment comes through operational efficiencies and cost savings.
Cost considerations for implementing IRT in clinical trials:
- Budget allocation: 2-3% of total study budget for most trials
- ROI factors: 15-20% drug waste reduction, fewer protocol deviations, faster database lock
- Value Drivers: Reduced monitoring costs, eliminated transcription errors, accelerated timelines
The investment in IRT often pays for itself through reduced drug waste, faster study completion, and improved operational efficiency throughout the trial lifecycle.
How does IRT manage drug supply chains?
IRT provides comprehensive drug supply management from manufacturing through patient dispensing, with real-time visibility and automated optimization. This system tracks inventory levels, manages expiration dates, forecasts future needs, and handles returns and destruction across all sites and depots.
Based on Suvoda's supply optimization research, effective IRT systems deliver:
IRT’s supply chain capabilities:
- Intelligent forecasting: Predicts future supply needs based on enrollment patterns
- Automated resupply: Triggers shipments before stock-outs occur
- Expiration management: Tracks lot numbers and prevents dispensing expired products
- Waste reduction: 15-20% decrease in drug waste through optimized distribution
- Patient-centric focus: Provides correct medication at the right time and place
This approach addresses the industry challenge where median waste levels reach 50%, significantly impacting both costs and environmental sustainability.
How does IRT support decentralized clinical trials?
IRT enables decentralized trials through direct-to-patient shipping, remote monitoring, and comprehensive logistics management. Some IRT vendors, like Suvoda IRT, include specialized modules for temperature-sensitive shipments and patient-centric workflows.
Key IRT features optimized for decentralized trials:
- Direct-to-patient shipping: Complete chain of custody tracking and compliance monitoring helps medications reach patients safely at home.
- Temperature excursion management: Advanced monitoring and excursion handling maintain cold chain integrity throughout the distribution process.
- Remote oversight: Real-time visibility into patient compliance and supply status across all locations, enabling proactive intervention when needed.
These capabilities support patient safety and regulatory compliance while enabling the flexibility needed for hybrid and fully decentralized trial models.
How does IRT integrat e with other systems?
Modern IRT systems provide comprehensive integration capabilities through APIs and pre-built connectors to major EDC, CTMS, and other eClinical platforms. Suvoda offers extensive integration options including two-way data synchronization and real-time communication.
Suvoda IRT’s integration capabilities:
- EDC: Seamless data transfer for endpoint collection
- CTMS platforms: Site management and trial oversight
- Laboratory systems: Real-time results and safety monitoring
- Supply chain systems: Depot management and logistics coordination
Proper integration eliminates manual data entry, reduces errors, and provides sponsors with comprehensive trial visibility across all systems.
How does IRT enable data security and compliance?
Modern IRT platforms implement enterprise-grade security including encrypted data transmission, access controls, and comprehensive audit trails. Suvoda maintains rigorous security standards including SOC 2 Type 2 compliance and international privacy regulations.
What therapeutic areas benefit from IRT?
The areas of oncology, CNS/neurology, and rare diseases in particular see benefits due to complex randomization and visit management requirements and specialized supply management needs. Suvoda specializes in these therapeutic areas with advanced features for adaptive designs and patient-centric trials.
Therapeutic area applications for Suvoda IRT:
- Oncology: Adaptive randomization, dose escalation, and biomarker-driven assignment
- CNS disorders: Complex stratification and safety monitoring requirements
- Rare diseases: Small patient populations and specialized distribution networks
- Cardiovascular: Long-term studies with extensive endpoint collection
- Immunology: Complex dosing regimens and safety monitoring
These areas benefit from IRT's ability to handle protocol complexity while maintaining regulatory compliance and patient safety standards.
What makes Suvoda IRT different from other vendors?
Suvoda stands out for being part of a unified platform, its Sofia AI assistant, and extensive configurability for complex studies. Unlike standalone IRT vendors, Suvoda's platform approach combines IRT with eConsent, eCOA, Patient Payments, Patient Travel, Scheduling, and the Greenphire Clinical Finance suite on a single data model.
Suvoda IRT’s key differentiators:
- Unified platform: Single data model across all products on the Suvoda Platform
- Sofia AI assistant: Conversational interface for drug supply management
- Complex study expertise: Specialized in oncology, CNS, and rare disease trials
- Modular, patented architecture: Rapid deployment and mid-study modifications
- Self-service capabilities: Reduce dependency on vendor for routine changes
This approach eliminates traditional system silos and reduces integration complexity for sponsors managing multiple eClinical technologies.
What is Sofia AI in Suvoda IRT?
Sofia is Suvoda's AI assistant that simplifies drug supply management through conversational interactions, reducing multi-screen processes to simple questions.
Sofia provides secure, accurate access to trial data while maintaining study blinding. It operates within existing security and permission frameworks, so that users only access data they're authorized to view while providing zero-day data retention for privacy protection. Users can access trial data, create visualizations, compare depot inventories, and search documentation simply by asking Sofia questions in natural language.
Contact our team